Win or lose, Pfizer can't seem to shake its addiction to buying its growth. With the acquisition of Wyeth, the world's largest pharmaceuticals company is trying again.
Pfizer's buying habit
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You